In this free webinar, gain insight into strategies to improve data quality monitoring in rare disease clinical trials, including eCOA form optimization,...
Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026...
TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ("Helix" or the "Company"), a clinical-stage...
Black Book Mid Year Update on Irish Health IT Adoption and Vendor Performance DUBLIN, IE / ACCESS Newswire / September...
NORTHAMPTON, MA / ACCESS Newswire / September 9, 2025 / Kidney disease affects an estimated 35 million Americans, with 90%...
Investment will accelerate GEOH's expansion as a leading end-to-end software and services platform for home care agencies. INDIANAPOLIS, IN /...
In an historic moment for regional solidarity and leadership, West African Ministers of Health pledge their joint commitment to advance...
Following new safety concerns from the U.S. Food and Drug Administration (FDA) regarding benzoyl peroxide (BPO) acne products, CLn Skin...
"Company anticipates achieving debt-free status by year-end, reinforcing commitment to AI-driven healthcare technologies" MESA, ARIZONA / ACCESS Newswire / September...
The new location expands access to advanced podiatric care in one of metro Atlanta's most active and growing communities. ATLANTA,...
First Wave of 10-Report Rollout Empowers IDNs with Faster Insights into Pharmacy Spend, Pricing, and Compliance GRAND RAPIDS, MI /...
CHICAGO, IL / ACCESS Newswire / September 9, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for...
Michael Castanon, Founder and CEO of Alter Behavioral Health, Has Been Nominated for Executive of the Year 2025 IRVINE, CALIFORNIA...
VANCOUVER, BC / ACCESS Newswire / September 9, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a...
SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage...
Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE...
New preclinical findings highlight Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene - often called...
- Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients -- Gemini could...
A Powerful, Educational Segment Unveils the Truth Behind Endometriosis, Fertility Challenges, and the Future of Women's Health MANHATTAN, NEW YORK...
DUBAI, AE / ACCESS Newswire / September 9, 2025 / UAE sports trends in 2025 are emphasizing holistic fitness and...